Natco Pharma to establish a subsidiary in Indonesia
Natco Pharma, a pharmaceutical company, has made the decision to establish a subsidiary in Indonesia with an expenditure of up […]
Say something
Natco Pharma, a pharmaceutical company, has made the decision to establish a subsidiary in Indonesia with an expenditure of up […]
Helping patients to reach doctors easily Practo, Asia’s largest healthcare booking platform, and Uber, the world’s leading ride-hailing technology platform, […]
Venture capital (VC) funding, including private equity and corporate venture capital, in the Health IT / Digital Health sector increased […]
Call to Include Family Planning in Sustainable Development Goals, Invest More in Womens Reproductive Rights India has inched closer to […]
India needs a RSBY like scalable model for providing healthcare protection to the poor, who are mostly working in the […]
US wants India to lift import ban on dairy products The US has sought to impress upon India to lift […]
The Planning Commission in their document- Faster, Sustainable and More Inclusive Growth: An Approach to the 12th Five Year Plan, […]
A new World Bank report titled ‘Public Policy and the Challenge of Chronic Non-communicable Diseases’ launched on 27 June, 2007 warns that poor countries are catching up with wealthier nations in terms of diseases like cancer, diabetes, obesity, and cardiac problems.
As the CFO of Columbia Asia Hospitals, Jagannath MS, delivers healthcare through the best model of hospitals and medical excellence.
The conference of
Narayana Hrudayalaya, the Bangalore-based heart care hospital, will increase its bed capacity to 30,000 in five years across all its hospitals across India.
Medsynaptic is an emerging medical informatics company in India with a diversified product range for the medical imaging industry.
InterSystems Awarded ‘Healthcare IT Company of the Year’ by Frost & Sullivan, following successful
implementations in China, India, Thailand, Japan, Taiwan, Indonesia, Malaysia, Australia, New Zealand and Singapore.